ARKG - Warren Buffett and Cathie Wood Just Bought This Juicy Dividend Stock. Should You?
Contrary to what you've heard, great minds don't always think alike. Just look at the stock picks made by Warren Buffett and Cathie Wood. There aren't many stocks on which these two well-known investors agree. But I can think of at least one notable exception.
Buffett's Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) added AbbVie (NYSE: ABBV) to its portfolio in the third quarter of last year. Berkshire bought even more shares of the big drugmaker in the fourth quarter. Meanwhile, Wood's ARK Genomic Revolution ETF (NYSEMKT: ARKG) scooped up shares of AbbVie in February .
What makes AbbVie so appealing to two very different investors like Buffett and Wood? And is the big pharma stock one that you should consider buying as well?
For further details see:
Warren Buffett and Cathie Wood Just Bought This Juicy Dividend Stock. Should You?